Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian G Feagan

Showing results (61-70 of 464) with videos related to

Pageof 47
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 30, 2013
A test-based strategy is more cost effective than empiric dose escalation for patients with Crohn's disease who lose responsiveness to infliximabFernando S Velayos, James G Kahn, William J Sandborn, et al.
Gastroenterology & Hepatology|June 17, 2021
The Guide to Guidelines in Ulcerative Colitis: Interpretation and Appropriate Use in Clinical PracticeWilliam J Sandborn, Brian G Feagan, Stephen B Hanauer, et al.
Gut|May 7, 2021
Methods for handling missing segments in Crohn's disease clinical trials: analysis from the EXTEND trialChristopher Ma, Reena Khanna, Leonardo Guizzetti, et al.
Journal of Crohn'S & Colitis|April 3, 2012
What do changes in inflammatory bowel disease management mean for our patients?Subrata Ghosh, Geert D'Haens, Brian G Feagan, et al.
Digestive Diseases and Sciences|March 25, 2014
An overview of magnetic resonance enterography for Crohn's diseaseSuresh Pola, Cynthia Santillan, Barrett G Levesque, et al.
Alimentary Pharmacology & Therapeutics|November 12, 2019
Editorial: evolving histological assessment of NASH. Authors' replyRish K Pai, Brian G Feagan, Claire E Parker, et al.
The Cochrane Database of Systematic Reviews|April 22, 2016
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitisYongjun Wang, Claire E Parker, Tania Bhanji, et al.
Gastrointestinal Endoscopy|December 23, 2020
Routine incorporation of the local read in Crohn's disease clinical trials? Not so fastVipul Jairath, Guangyong Y Zou, Christopher Ma, et al.
The Cochrane Database of Systematic Reviews|December 14, 2012
Methotrexate for induction of remission in refractory Crohn's diseaseJohn W D McDonald, David J Tsoulis, John K Macdonald, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 8, 2019
Infliximab Exposure-Response Relationship and Thresholds Associated With Endoscopic Healing in Patients With Ulcerative ColitisNiels Vande Casteele, Jenny Jeyarajah, Vipul Jairath, et al.
Pageof 47

Showing results (61-70 of 464) with videos related to

Sort By:
Pageof 47
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 30, 2013
A test-based strategy is more cost effective than empiric dose escalation for patients with Crohn's disease who lose responsiveness to infliximabFernando S Velayos, James G Kahn, William J Sandborn, et al.
Gastroenterology & Hepatology|June 17, 2021
The Guide to Guidelines in Ulcerative Colitis: Interpretation and Appropriate Use in Clinical PracticeWilliam J Sandborn, Brian G Feagan, Stephen B Hanauer, et al.
Gut|May 7, 2021
Methods for handling missing segments in Crohn's disease clinical trials: analysis from the EXTEND trialChristopher Ma, Reena Khanna, Leonardo Guizzetti, et al.
Journal of Crohn'S & Colitis|April 3, 2012
What do changes in inflammatory bowel disease management mean for our patients?Subrata Ghosh, Geert D'Haens, Brian G Feagan, et al.
Digestive Diseases and Sciences|March 25, 2014
An overview of magnetic resonance enterography for Crohn's diseaseSuresh Pola, Cynthia Santillan, Barrett G Levesque, et al.
Alimentary Pharmacology & Therapeutics|November 12, 2019
Editorial: evolving histological assessment of NASH. Authors' replyRish K Pai, Brian G Feagan, Claire E Parker, et al.
The Cochrane Database of Systematic Reviews|April 22, 2016
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitisYongjun Wang, Claire E Parker, Tania Bhanji, et al.
Gastrointestinal Endoscopy|December 23, 2020
Routine incorporation of the local read in Crohn's disease clinical trials? Not so fastVipul Jairath, Guangyong Y Zou, Christopher Ma, et al.
The Cochrane Database of Systematic Reviews|December 14, 2012
Methotrexate for induction of remission in refractory Crohn's diseaseJohn W D McDonald, David J Tsoulis, John K Macdonald, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 8, 2019
Infliximab Exposure-Response Relationship and Thresholds Associated With Endoscopic Healing in Patients With Ulcerative ColitisNiels Vande Casteele, Jenny Jeyarajah, Vipul Jairath, et al.
Pageof 47